Mark W. Kroll is Director at HAEMONETICS CORP (HAE). They have made 19 open-market trades across 3 companies since 2012, most recently 2026-07-24.
CIK 0001259254
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $99K since 2025, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AXON | 11,135 | $4.3M |
| HAE | 27,295 | $3.2M |
| AAXN | 17,607 | $3.1M |
| TASR | 48,225 | $1.1M |
| Total | $11.7M |
Shares reported on the most recent Form 4, priced at the 2026-07-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HAE | BUY | 2025-11-10 | 2025-11-12 | $70.56 | $99K | +8.7% | +14.0% | -18.8% |
| AXON | SELL | 2023-03-07 | 2023-03-08 | $220.72 | $1.5M | -3.4% | +0.6% | -12.0% |
| HAE | SELL | 2022-08-15 | 2022-08-16 | $73.71 | $1.2M | -0.2% | +3.2% | +3.2% |
| AXON | SELL | 2022-06-08 | 2022-06-09 | $102.82 | $650K | -12.1% | -4.7% | +26.0% |
| HAE | SELL | 2021-05-26 | 2021-05-28 | $55.10 | $1.3M | +4.4% | +21.7% | +6.4% |
| AXON | SELL | 2021-05-12 | 2021-05-14 | $124.94 | $1.1M | +4.1% | +20.1% | +42.6% |
| AAXN | SELL | 2020-11-16 | 2020-11-17 | $120.44 | $721K | +5.1% | +0.9% | N/A |
| HAE | SELL | 2020-04-09 | 2020-04-13 | $102.00 | $1.1M | +13.6% | -2.9% | -12.5% |
| AAXN | SELL | 2019-11-13 | 2019-11-14 | $64.30 | $536K | +14.2% | +8.7% | +30.6% |
| HAE | SELL | 2018-11-07 | 2018-11-09 | $114.00 | $1.2M | -7.9% | -6.1% | -23.3% |
| AAXN | SELL | 2018-08-20 | 2018-08-20 | $64.34 | $913K | +3.6% | +5.0% | -26.7% |
| HAE | SELL | 2018-01-02 | 2018-01-03 | $63.00 | $448K | +1.8% | +1.0% | +14.5% |
| HAE | SELL | 2017-05-15 | 2017-05-17 | $41.47 | $73K | +1.4% | +1.1% | +5.3% |
| HAE | SELL | 2017-05-15 | 2017-05-17 | $41.49 | $366K | +1.4% | +1.1% | +5.3% |
| HAE | SELL | 2015-02-27 | 2015-03-03 | $44.80 | $507K | -4.4% | -2.0% | -2.0% |
| AAXN | SELL | 2014-12-16 | 2018-06-29 | $22.85 | $71K | +7.7% | +3.8% | +5.6% |
| HAE | SELL | 2012-11-19 | 2012-11-21 | $80.13 | $368K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2012-11-16 | 2012-11-20 | $79.67 | $478K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2012-05-04 | 2012-05-08 | $71.09 | $1.4M | -4.4% | -2.0% | -2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.